InvestorsHub Logo
Followers 3
Posts 389
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Thursday, 08/18/2016 6:33:43 PM

Thursday, August 18, 2016 6:33:43 PM

Post# of 17421
Aurinia Pharmaceuticals (AUPH) Plunges Despite Upbeat Trial Data

What should have been a big win for Aurinia Pharmaceuticals Inc.'s stock (NASDAQ:AUPH) Monday on the back of positive phase IIb data in the particularly tough lupus nephritis (LN) indication turned into a drubbing for the shares, which plunged 56 percent as investor attention focused - perhaps unfairly - on the study's death rate.

http://tjcnewspaper.com/aurinia-pharmaceuticals-auph-plunges-despite-upbeat-trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News